… been used to overcome subfertility, and ovarian stimulation (OS) is considered an important
… follicle-stimulating hormone (FSH) with a gonadotropin-releasing hormone (GnRH) analog, …

… The results, as presented in Table 3, demonstrate no significant difference in reducing the
number of days of ovarian stimulation and FSH consumption. In addition, no difference was …

… consumption, and 3) reduced development of small ovarian follicles. These features can
be exploited to develop regimens that optimize treatment outcome, lower costs, and reduce …

… -releasing hormone (GnRH) agonists for ovarian stimulation marks … Premature surges of
luteinizing hormone (LH) had been found to … rates and the consumption of HMG were compared. …

… This results in an extension of the follicle-stimulating hormone (FSH) … of stimulation and
higher gonadotropin consumption were … Ovarian stimulation was started on day 5 after COCP …

… following ovarian stimulation, resulting in a greater need for r-hFSH (>2500 IU).[ 32 ] In
another preliminary study, the total r-hFSH consumption was elevated during ovarian stimulation …

… ovarian follicles depends on the sequential effects of the two principal gonadotropins,
follicle-stimulating hormone (FSH) and luteinising hormone … , but not with FSH consumption [46]. …

… ovarian stimulation was greatest in the 100 IU/day dose group. The risk of developing ovarian
… The use of GnRH antagonist as co-treatment might lead to an even lower consumption of …

… hormone (GH) or growth hormone-releasing hormone (GH-… risk of cyst formation and no
hormonal withdrawal symptoms [144–146]. … consumption and shorter durations of stimulation in …

… In comparison to the long protocol with HMG and GnRH agonists, which in our clinic needed
35—40 ampoules for ovarian stimulation, the gonadotrophin consumption was significantly …